Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Opicapone is a peripherally selective inhibitor of catechol-O-methyltransferase (COMT).1 It inhibits COMT activity in rat liver, but not brain, homogenates (ED50 = 1.05 mg/kg). Opicapone (3 mg/kg) increases plasma levels of L-DOPA (Item No. 13248) and reduces plasma levels of 3-O-methyl-DOPA (3-OMD) when administered in combination with benserazide (Item No. 20298) and L-DOPA.2 Formulations containing opicapone have been used as adjuvants in the treatment of “off” episodes associated with Parkinson’s disease.
WARNING This product is not for human or veterinary use.
1. Discovery of a long-
2. Pharmacological profile of opicapone, a third generation nitrocatechol catechol-